New delhi: Zydus lifescienes on tuesday said it has entred into negotiation to acquire a majority stake in france-based Amplitude surgicalA Medtech Firm, for 256.8 Million Euro (Around Rs 2,500 Crore). The company is in talks with pai partners and amplitude surgical's management, and two minority sharehlders, for 85.6% of the firm's stake at 6.3 euro per share.
The acquisition price represents a 81% premium over the last closing price as on March 10 and Premium of 88.2% and 92.2% over the three-month and SIX-Month Volume-Wighted AVEGHTED AAVEGHTED AMPLITUDEE Surgical Respectedly, Says a Company Statement. The proposed acquisition will serve as a strategic platform for zydus to advance its global medtech amables, Leveraging its established expertise in Life Sciences and Wellles for Furness for Furness for Fur
Amplitude surgical is a European medtech firm in high-quality, lower-limb orthopaedic technologiesZydus Life Plans to Initiate a Tender Offer to Acquire the Full Stake after the account at the same purchase price of 6.3 euro per amplitude surgical share. Following the completion of the mandatory tender offer, the company aims to acquire 100% of amplitude surgical's equity shares, and to delist the company. As of June 30, 2024, Amplitude Surgical Reported A Turnover of 106 Million Euro (Around 1,000 Crore).
Sharvil Patel, MD, Zydus Lifescienes, said: “Our legacy in science, Health and Innovation Has enabled a Deep Understanding of Patient Journey and their care pathways. We believe this was a natural extension in the field of medical technology. ”
(Tagstotranslate) Business News (T) Zydus Lifescienes (T) Zydus Acquisition News (T) Orthopaedic Technologies (T) Medtech Acquisition (T) Investment in Medical Technology (T) Health and Innovation (T) French Medtech Firm (T) European Medtech (T) amplitude surgical
Leave a Reply